| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jul 23, 2024
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the second quarter of fiscal year...
-
Jul 4, 2024
The diagnostics company has implemented the SOPHiA DDM™ Platform to enhance its solid tumor testing BOSTON and ROLLE, Switzerland, July 4, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a...
-
Jun 24, 2024
Novel application supports measurable residual disease (MRD) testing to help monitor cancer and stay ahead of relapse BOSTON and ROLLE, Switzerland, June 24, 2024 /PRNewswire/ -- SOPHiA GENETICS...
-
Jun 13, 2024
The Hospital will use SOPHiA DDM™ to enhance its testing and research of blood cancers BOSTON and ROLLE, Switzerland, June 13, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native...
-
May 30, 2024
New collective intelligence network to enable the most advanced research in oncology in support of precision medicine BOSTON and ROLLE, Switzerland , May 30, 2024 /PRNewswire/ -- SOPHiA GENETICS...
General Inquiries
SOPHiA GENETICS
La Pièce 12, CH-1180
Rolle, Switzerland
+41 21 694 10 60
Transfer Agent
Computershare Trust Company, N.A.
Courier Delivery:
P.O. Box 43006
Providence RI 02940-3006
Overnight Delivery:
150 Royall St. STE 101
Canton, MA 02021
877.373.6374
www.computershare.com